T1	Disorder 104 132	acute lymphoblastic leukemia
T4	Disorder 175 192	immunocompromised
T5	Method_cue 796 804	CT scans
T6	Disorder 655 658	PCP
T8	Anatomical_entity 764 768	lung
T9	Anatomical_entity 956 960	sera
T10	Artificial_process 514 517	BMT
T12	Disorder 471 474	PCP
T15	Subject 93 98	child
T16	Disorder 441 444	IPF
T17	Disorder 410 439	idiopathic pulmonary fibrosis
T19	GGPs 573 577	SP-D
T20	Disorder 57 87	Pneumocystis carinii pneumonia
T21	GGPs 0 20	Surfactant protein D
T23	Disorder 167 170	PCP
T25	GGPs 278 298	surfactant protein D
T27	Method_cue 774 785	chest X-ray
T30	Artificial_process 994 1003	treatment
T31	Subject 460 465	child
T32	Anatomical_entity 262 267	Serum
T36	Disorder 135 165	Pneumocystis carinii pneumonia
T37	Artificial_process 485 512	bone marrow transplantation
T38	Anatomical_entity 665 670	serum
T39	Disorder 1016 1019	PCP
T40	Disorder 523 551	acute lymphoblastic leukemia
T42	Disorder 892 895	PCP
T46	GGPs 939 943	SP-D
T47	GGPs 300 304	SP-D
T48	Anatomical_entity 590 594	sera
T49	Subject 396 404	patients
T51	GGPs 682 686	SP-D
T55	Anatomical_entity 360 369	pulmonary
T56	Disorder 858 877	respiratory failure
E2	Artificial_process:T10 
E3	Artificial_process:T30 disorder:T39
E4	Artificial_process:T37 Theme:T31 disorder:T40
N3	Reference T1 UMLS:C0023449	Acute lymphocytic leukemia
N12	Reference T4 UMLS:C0085393	Immunocompromised Host
N14	Reference T5 UMLS:C0040405	X-Ray Computed Tomography
N16	Reference T6 UMLS:C1535939	Pneumocystis jiroveci pneumonia
N25	Reference T8 UMLS:C0024109	Lung
N29	Reference T9 UMLS:C0229671	Serum
N31	Reference E2 UMLS:C0005961	Bone Marrow Transplantation
N34	Reference T12 UMLS:C1535939	Pneumocystis jiroveci pneumonia
N44	Reference T15 UMLS:C0008059	Child
N46	Reference T16 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
N48	Reference T17 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
N59	Reference T19 UMLS:C0084692	Pulmonary Surfactant-Associated Protein D
N60	Reference T20 UMLS:C1535939	Pneumocystis jiroveci pneumonia
N68	Reference T21 UMLS:C0084692	Pulmonary Surfactant-Associated Protein D
N73	Reference T23 UMLS:C1535939	Pneumocystis jiroveci pneumonia
N83	Reference T25 UMLS:C0084692	Pulmonary Surfactant-Associated Protein D
N89	Reference T27 UMLS:C0039985	Plain chest X-ray
N102	Reference E3 UMLS:C0087111	Therapeutic procedure
N109	Reference T31 UMLS:C0008059	Child
N114	Reference T32 UMLS:C0229671	Serum
N121	Reference T36 UMLS:C1535939	Pneumocystis jiroveci pneumonia
N124	Reference E4 UMLS:C0005961	Bone Marrow Transplantation
N129	Reference T38 UMLS:C0229671	Serum
N130	Reference T39 UMLS:C1535939	Pneumocystis jiroveci pneumonia
N134	Reference T40 UMLS:C0023449	Acute lymphocytic leukemia
N139	Reference T42 UMLS:C1535939	Pneumocystis jiroveci pneumonia
N154	Reference T46 UMLS:C0084692	Pulmonary Surfactant-Associated Protein D
N161	Reference T47 UMLS:C0084692	Pulmonary Surfactant-Associated Protein D
N165	Reference T48 UMLS:C0229671	Serum
N166	Reference T49 UMLS:C0030705	Patients
N180	Reference T51 UMLS:C0084692	Pulmonary Surfactant-Associated Protein D
N194	Reference T55 UMLS:C0024109	Lung
N195	Reference T56 UMLS:C1145670	Respiratory Failure
T58	Disorder 815 840	ground-glass attenuations
N4	Reference T58 UMLS:C3827002	Ground Glass Opacity
T57	GGPs 25 29	KL-6
N2	Reference T57 UMLS:C0057628	Mucin-1 protein
T59	GGPs 310 314	KL-6
N5	Reference T59 UMLS:C0057628	Mucin-1 protein
T60	GGPs 582 586	KL-6
N6	Reference T60 UMLS:C0057628	Mucin-1 protein
T61	GGPs 691 695	KL-6
N7	Reference T61 UMLS:C0057628	Mucin-1 protein
T62	GGPs 948 952	KL-6
N8	Reference T62 UMLS:C0057628	Mucin-1 protein
R1	Subject_Disorder Arg1:T15 Arg2:T1	
R2	Subject_Disorder Arg1:T49 Arg2:T17	
R3	Subject_Disorder Arg1:T31 Arg2:T12	
T52	Gene_expression 671 677	levels
E1	Gene_expression:T52 Theme:T61 atLoc:T38
N9	Reference E1 UMLS:C1519614	Genetic Translation Process
E5	Gene_expression:T52 Theme:T51 atLoc:T38
N11	Reference E5 UMLS:C1519614	Genetic Translation Process
T63	Positive_regulation 709 717	elevated
E7	Positive_regulation:T63 Theme:E5 Cause:E10
N15	Reference E7 UMLS:C1879547	Activation action
T18	Biological_process 370 392	inflammatory responses
E9	Positive_regulation:T63 Theme:E1 Cause:E10
N18	Reference E9 UMLS:C1879547	Activation action
T44	Biological_process 734 756	inflammatory processes
E10	Biological_process:T44 atLoc:T8 Cue:T3 Cue2:T27 Cue3:T5 disorder:T58
N21	Reference E10 UMLS:C1155266	inflammatory response
E11	Biological_process:T18 disorder:T17 Theme:T55
N22	Reference E11 UMLS:C1155266	inflammatory response
T2	Disorder 553 556	ALL
N1	Reference T2 UMLS:C0023449	Acute lymphocytic leukemia
R10	Subject_Disorder Arg1:T15 Arg2:T20	
T7	Biological_process 846 850	died
E12	Biological_process:T7 
N17	Reference E12 UMLS:C0011065	Cessation of life
T3	Speculation_cue 805 811	showed
T35	Subject 193 201	patients
N20	Reference T35 UMLS:C0030705	Patients
R11	Subject_Disorder Arg1:T35 Arg2:T4	
R5	Subject_Disorder Arg1:T35 Arg2:T36	
T45	Biological_process 896 905	developed
E13	Biological_process:T45 Theme:T42
N23	Reference E13 UMLS:C0699748	Pathogenesis
T34	Positive_regulation 851 857	due to
E8	Positive_regulation:T34 Cause:T56 Theme:E12
N10	Reference E8 UMLS:C1879547	Activation action
R14	Subject_Disorder Arg1:T31 Arg2:T40	
